Search

Your search keyword '"Salani, Ritu"' showing total 742 results

Search Constraints

Start Over You searched for: Author "Salani, Ritu" Remove constraint Author: "Salani, Ritu"
742 results on '"Salani, Ritu"'

Search Results

201. The association between histological subtype of a first primary endometrial cancer and second cancer risk.

202. Nomogram for Predicting Individual Survival After Recurrence of Advanced-Stage, High-Grade Ovarian Carcinoma.

203. Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus

204. Is age a prognostic biomarker for survival among women with locally advanced cervical cancer treated with chemoradiation? An NRG Oncology/Gynecologic Oncology Group ancillary data analysis.

205. No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer

206. Cytochrome P450--inhibiting/inducing Medication Use Among Patients With Advanced Ovarian Cancer (aOC) Who Received or Were Eligible for Poly(ADP-ribose) Polymerase Inhibitors (PARPis) as First-line Maintenance Therapy.

207. Colaboradores

209. Is age a prognostic biomarker for survival among women with locally advanced cervical cancer treated with chemoradiation? An NRG Oncology/Gynecologic Oncology Group ancillary data analysis

210. No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer

213. A Prospective, Comparative Study for the Evaluation of Postoperative Pain and Quality of Recovery in Patients Undergoing Robotic Versus Open Hysterectomy for Staging of Endometrial Cancer

215. Colaboradores

217. Time to consider integration of a formal robotic-assisted surgical training program into obstetrics/gynecology residency curricula.

228. Evaluation of the Hematologic Safety of Same Day Versus Standard Administration (24- to 72-Hour Delay) of Pegfilgrastim in Gynecology Oncology Patients Undergoing Cytotoxic Chemotherapy

230. The Use of Transvaginal Ultrasound in Type II Endometrial Cancer

231. A limited access phase I trial of paclitaxel, cisplatin and ABT-888 in the treatment of advanced, persistent, or recurrent carcinoma of the cervix: An NRG/GOG study.

234. Extending the screening interval: Is longer better?

235. Contributors

236. BRCA mutation in ovarian cancer: testing, implications and treatment considerations.

237. An update on post-treatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncology (SGO) recommendations.

242. Does intra-operative radiation at the time of pelvic exenteration improve survival for patients with recurrent, previously irradiated cervical, vaginal, or vulvar cancer?

245. Reply

246. Evaluation of the hematologic safety of same day versus standard administration of pegfilgrastim in gynecology oncology patients undergoing platinum-based chemotherapy.

248. Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer

249. Breast and gynecologic cancer-related extremity lymphedema: a review of diagnostic modalities and management options.

Catalog

Books, media, physical & digital resources